Logo | Name | Σ | Employees | ||
---|---|---|---|---|---|
Eden Autism To improve the lives of people with autism: one individual at a time; one family at a time; one community at a time. Eden Autism is a primary resource for autism information, education, training, and support. Since 1975, Eden, a not-for-profit organization, has provided early intervention, education, employment training, and residential services for children and adults with autism. Eden offers both in-person and online support and training programs for families and professionals. Recognized nationally, Eden is headquartered in Princeton, NJ. Applied Behavior Analysis, Adult Employment Services, Residential Services, Early Intervention Services, Education Services for 3 to 21, Teacher Training, Home … Type: SMB Activities: edtech Technologies: Synthetic Biology | 2 | 0 | 2 | 299 | |
NeuroPace The NeuroPace RNS System is the only brain-responsive neurostimulation system for refractory focal epilepsy. Rx Only. The RNS® System is an award-winning technology developed and manufactured in Silicon Valley that has been recognized for its innovation. Similar to a pacemaker that monitors and responds to heart rhythms, the RNS System is the world's first and only medical device that can monitor and respond to brain activity. NeuroPace was founded to design, develop, manufacture and market implantable devices for the treatment of neurological disorders with responsive stimulation. The company's initial focus is the treatment of epilepsy, a debilitating neurological disorder affecting … Type: SMB Activities: healthtech deeptech manufacturing Technologies: Synthetic Biology | 3 | 1 | 2 | 204 | |
Lin Engineering - Motor Specialists in Motion Motion Control, Solved - Motor Engineering and Manufacturing. We design, engineer, and manufacture stepper motors, BLDC motors, linear actuators, and other motion control products. Our products are routinely used in medical devices, aerospace crafts, autonomous vehicles, automation assemblies, and many other applications. Thousands of Engineers from around the world rely on the accuracy, reliability, and consistency of our products as well as our top-notch support. Stepper Motors, Motion Control, Brushless DC Motors, Application Optimization, Linear Actuators, Medical Motion Control , Aerospace Motion Control, and Automotive Motion Control Type: SMB Activities: industry 4.0 Technologies: Synthetic Biology | 0 | 0 | 0 | 96 | |
Phacilitate Through conferences, community and market insights, we create partnerships that help advance the next pillar of medicine Phacilitate creates an environment where promising innovation can turn into the products that are changing the future of medicine. Recognised as the market leader in providing the life science sector with strategic insight, inspiration and unparalleled business networking, Phacilitate enables professionals to stay abreast of the issues driving life science innovation. #advancedtherapies #biotech #celltherapy #genetherapy Clinical Development, Cell Therapy, Gene Therapy, Oncology, Cancer, Precision Medicine, Biotech, Advanced Therapy, Biotechnology, and Life Sciences Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 21 | 1 | 19 | 17 | |
MSD Sverige [Automatic translation follows] Research and innovation for patients is our lifeblood. This is how we contribute to a strong life science arena in Sweden. MSD Sweden's official LinkedIn. About us: http://www.msd.se/om-oss/ Life at MSD http://www.workforlife.com/ Follow us on Twitter under the name @MSDSverige We are on Youtube under the name @Innovation Sweden Questions about MSD medicines: medicinskinfo@merck.com. Adverse event reporting: pv.sweden@merck.com. Complaints: mmd.pqc.hh.sweden.chu@merck.com. Oncology, Diabetes, Hospital Specialty Care, Cardiovascular, Vaccines, and Women's Health Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 6 | 0 | 4 | 93 | |
NDA Group - an SSI Strategy Company Let's bring medicines to the world, because the world is waiting NDA Group is the regulatory powerhouse of SSI Strategy. For more than 25 years we’ve leveraged our extensive experience and global network to help you optimize your regulatory strategies, expedite filings, and secure successful approvals in key markets worldwide. By integrating our regulatory proficiency with SSI Strategy's strategic capabilities in clinical development, medical affairs and commercial planning, we provide biotech companies with a holistic solution that maximizes the value of their assets and ensures timely access to innovative therapies. We understand that bringing a new therapy to market is … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 0 | 1 | 131 | |
Fitabeo Therapeutics Innovating to Enhance Quality of Life Fitabeo Therapeutics is a clinical-stage specialty pharmaceutical company that develops and commercialises a differentiated portfolio of innovative medicines focusing on indications where existing treatments are inadequate for the target population. It deploys breakthrough technologies to develop medicines that enable patient autonomy, decentralise patient care and provide superior health outcomes. Oral Thin Films, Geriatrics, Paediatrics, Patient autonomy, Equitable Access, Innovative medicines, Medication adherence, Central Nervous System, Women's Health, and Neurology Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 5 | |
Genewity B.V. Genewity B.V. is a recently founded biotech company based in Leiden, the Netherlands. Closely collaborating with the LUmc, we build on successes of our scientific and business teams in cell and gene therapies, including the first multi-centric clinical trial for gene therapy in the EU (the RAG1 SCID trial). Genewity has been founded to commercialize another potentially groundbreaking therapy for developing autologous thymus tissue de novo. Genewity is currently in a preclinical development stage and is engaged in raising a Series A to push the technology to the clinic. Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 14 | |
MiMARK Discovering new biomarkers for Women’s Health In MiMARK, we care for women's health. We are specialized in the discovery, verification and validation of biomarkers to develop new solutions for gynecological patients. Abnormal uterine bleeding affects 14M between women in EU and US yearly (in women between 50 and 75 years old). Diagnosis of endometrial cancer is mandatory for all those women as 10% of those will be diagnosed with the disease. Current diagnosis is based on the pathological examination of an endometrial biopsy (pipelle biopsy), but this fails to diagnose in up to 30% of patients, and provides an inaccurate … Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 4 | 1 | 3 | 23 | |
EBAMed Ultrasound Guidance during Radio Ablation Treatment of Cardiac Arrhythmias EBAMed (External Beam Ablation Medical Devices) is developing an Ultrasound Imaging Solution to enable non-invasive treatment of Cardiac Arrhythmias. The device (CardioKit) offers the following functionalities: target position verification before treatment (to aid in patient setup), Cardiac Motion Monitoring during treatment, Respiratory Gating and Cardiac Gating. Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 12 | |
Hooke Bio Ltd. Biotech Startup who have developed a fully integrated high throughput screening system for 3D microtissues Hooke Bio Ltd. was founded in 2014 by Professor Mark Davies at Stokes Laboratories, University of Limerick (UL), a research center which has a rich history of microfluidic entrepreneurship. Hooke Bio spun out from the UL in 2017 and is currently based in Shannon, Co. Clare, Ireland. The company is named after Robert Hooke (scientist, astronomer, engineer and architect). He was the first person to image a microorganism using a microscope and coined the term "cell". Prior to 2017, Hooke Bio was funded by two … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 13 | |
Hooked Foods Leading the protein transformation for healthier people & planet Leading the transition to a healthier marine ecosystem by serving delicious plant-based seafood for everyone to enjoy. Type: Startup Activities: foodtech Technologies: Synthetic Biology | 2 | 2 | 0 | 19 | |
Hamlet BioPharma An innovative pharmaceutical company with a broad portfolio of projects for the treatment of cancer and infections Hamlet BioPharma AB is a pharmaceutical company with strong links to research, working with natural and biological substances. The company was formed through the merger of two pharmaceutical companies, Hamlet Pharma AB and SelectImmune Pharma AB, and is listed on the Spotlight Stock Market. Hamlet BioPharma is a formidable pharmaceutical company specializing in the development of drugs for the treatment of cancer and infectious diseases. The company has a portfolio of a total of ten drug projects, three of which are in Phase … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 8 | |
Cytovation Creating transformative medicines for patients with cancer Cytovation is a clinical stage immuno-oncology biotech developing first-in-class immunotherapies. CyPep-1, its lead asset, is a synthetic peptide engineered to selectively target tumor cells. CyPep-1 has a unique dual MoA applicable across solid tumors: (1) direct tumor-specific membrane lysis and in-situ vaccination, combined with (2) immune activation through inhibition of the β-catenin pathway. Building on strong FIH clinical data, Cytovation is advancing CyPep-1 to POC/pivotal clinical development with a focus on b-catenin-driven cancers. Biotech, Oncology, and Immuno-oncology Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 13 | |
Mighty Well Mighty Well creates innovative products in the Adaptive Wear market, which is expected to reach $393B by 2026 (CBS News), for the 133 million Americans who live with a chronic condition. Mighty Well applies sportswear fabric technology to the medical industry and is building a digital supportive community of Friends in the Fight for our consumers. We are leading the global charge of helping patients and caregivers turn sickness into strength. Mighty Well was Co-Founded out of CEO, Emily Levy's, experience as a patient battling Lyme disease and living with long term medical devices. Type: Startup Activities: healthtech fashtech Technologies: Synthetic Biology | 5 | 2 | 5 | 1 | |
Nano3D Biosciences Nano3D Biosciences (n3D) is a biotechnology startup located in Houston, TX focused on 3D cell culture solutions for biomedical research, drug discovery, toxicology, precision medicine, and regenerative medicine. Our core technology, magnetic 3D bioprinting, works by magnetizing cells and aggregating them with magnetic forces into models that represent native tissue environments. The advantages of this platform over other 3D cell culture and bioprinting platforms are speed, ease, and handling. n3D offers products and services around this technology, with a worldwide distribution network, including an OEM partnership with Greiner Bio-One Cell culture, Assay development, 3D cell culture, Precision medicine, Toxicology, and … Type: Startup Activities: biotech healthtech deeptech Technologies: 3D Printing Synthetic Biology | 1 | 0 | 0 | 1 | |
StemTek Therapeutics StemTek Therapeutics is a start-up biotechnolgy company dedicated to accelerating drug discovery in cancer using cutting edge technology, world-class science and a stem cell centric point of view for cancer therapy. Our mission is to help design novel treatments for cancer targeting cancer stem cells. Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 0 | 1 | 1 | |
WHEYD Stomach-friendly Protein Powders Designed for Elite Level Athletes To Improve Performance and Recovery. Simply put, our whey is different to the rest, as is the way we do business and work with suppliers & amazing customers. We provide the highest quality, stomach-friendly, Irish whey protein in delicious flavours, both in single-serve sachets and larger bags. We help those looking to increase their protein intake (20g per portion), while keeping their fat and sugar intake low. By providing the lowest calorie whey protein (86 calories a portion), sustainably sourced from Irish dairy cows, we aim to revolutionise the world of whey … Type: Startup Activities: healthtech sporttech Technologies: Synthetic Biology | 0 | 0 | 0 | 2 | |
Medica Media Medica Media provides print, web-based and mobile media solutions for medical professionals. Written by doctors for doctors. Makers of PocketDr. PocketDr is the must-have app for all junior doctors with on-call responsibilities. It is an aide-memoire for the things you know - but may not recall quickly in the dead of night with constant bleeps and distractions. Succinct. Pre-digested info. When you need it. Contents include: - Checklists for assessment of the deteriorating patient. Be prepared for any NEWS call: Hypoxia, Tachycardia, Hypotension, low GCS. - Checklists for management of 21 acute medical conditions including: ACS, AF, Asthma, Delerium, Hyperkalaemia, … Type: Startup Activities: healthtech it services Technologies: Synthetic Biology | 12 | 2 | 11 | 1 | |
Nascent Biotech, Inc. Nascent’s development approach utilizes the immune system’s innate capabilities and selectivity. Nascent Biotech, Inc. (OTCMKTS:NBIO) is a public company, formed in March 2014, to continue development of Pritumumab, a human monoclonal antibody created by a number of leading scientists who have developed various monoclonal antibodies and cytokine treatments for oncology indications. Pritumumab recognizes a unique and proprietary antigen expressed on the surface of cancer cells and is being developed to treat brain and pancreatic cancers, both unmet clinical needs. NBIO’s clinical premise is that the most effective way to treat disease is to modulate (boost or suppress) the human body’s … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 1 | |
NestEgg Labs Clever Automation Made Simple NestEgg Labs is a company providing innovative lab automation tools for cell culture applications. We are developing the Ovation hardware along with software to control it remotely and sterile disposable parts. Ovation, our flagship product, is a smart incubator that automates cell culture processes and cellular assays. The combination of powerful lens-free microscopy and fluid handling reduces experimental errors and time consuming activities. The system allows for a range of workflows to be reliably automated remotely using cloud-based software. Ovation is an affordable, flexible, and fully controllable laboratory automation system that ensures a smoother workflow in … Type: Startup Activities: biotech deeptech Technologies: 3D Printing Synthetic Biology | 3 | 1 | 3 | 5 | |
The Care Machine Ltd Helping you scale-up your ideas and create a resilient business with compelling products that will change people's lives Our mission is to produce bespoke solutions for you by combining our unique engineering and science expertise with our business knowledge, project management and media engagement know-how. From advice on funding streams, to design and manufacture processes, to full project management of your idea, we can help you realise your goals and get your product where it needs to be; with the patient. Unlike other B2B consultancies, The Care Machine works in partnership with our medtech clients. We have created an adaptive … Type: Startup Activities: healthtech deeptech govtech Technologies: Synthetic Biology | 5 | 0 | 2 | 1 | |
Access to Medicine Foundation Moving pharmaceutical companies to expand access to their products in low- & middle-income countries The Access to Medicine Foundation is an independent non-profit organisation based in the Netherlands. We seek to transform the healthcare ecosystem by motivating and mobilising companies to expand access to their essential healthcare products in low- and middle-income countries. Over the past two decades, we have demonstrated the power of data, collaboration and persuasion to trigger action by the pharmaceutical industry and scale up access to products. Our tried-and-tested approach involves defining the actions that healthcare companies should take, analysing what companies are actually doing, and … Type: SMB Activities: healthtech biotech civictech deeptech Technologies: Synthetic Biology | 36 | 9 | 31 | 52 | |
Bridge2Food Bringing together the world’s leading and most innovative plant-based food and alternative protein creators. Bridge2Food brings together the world’s leading and most innovative plant-based food and alternative protein creators. Our mission is to achieve global food sustainability for future generations to come, without compromising on food experience. We connect professionals across the value chain who share this goal, and together we will build a better food world. Community, Plant-Based Foods, Proteins, Active Nutrition, EcoSystems, Summits + Expo, Conferences, Courses, Academy, and alternative proteins Type: SMB Activities: foodtech Technologies: Synthetic Biology | 18 | 5 | 14 | 17 | |
FIC | Food Industry Consulting Food Safety is a Global Effort. Let's Save Lives Together. Food Industry Consulting (FIC), founded in 2008 by Soheila (Sonia) Akbarzadeh is a consulting firm that provides expert guidance and training to food companies in food safety and product development. Our team of food safety and food technologist specialists are dedicated to helping our clients run superior food safety programs and develop innovative products. We deliver live-virtual and on-site training for standardized Food Safety Preventive Controls Alliance (FSPCA) courses recognized by the U.S Food and Drug Administration (FDA). These courses include Preventive Controls (PC) for Human and Animal food, Foreign … Type: Startup Activities: foodtech Technologies: Synthetic Biology | 32 | 10 | 22 | 44 | |
Scaled Biolabs Inc. Working at the frontier of microfluidics, automation and machine learning to accelerate cell-based medicines. Scaled Biolabs accelerates the discovery and development of complex cell-based medicines, such as stem cell therapies and cancer immunotherapies. Their full stack optimization engine reduces complexity and time to market, by leveraging high-throughput, micro-scale cell culture, automation, and deep data insight. It also powers internal, grant funded programs such as developing a new gold standard for manufacturing dopaminergic neurons to treat Parkinson’s disease. Microfluidics, Biomedical R&D, Bioreactor, Single-cell Biology, Bioengineering, Stem Cells, Tissue Engineering, Cell Culture, Cell-based Assays, machine learning, and computer vision Type: Startup Activities: biotech deeptech Technologies: A.I. - Image Processing A.I. - Machine Learning A.I. Synthetic Biology | 0 | 0 | 0 | 1 | |
IDEABATIC SMILE- Smart last-mile Cooling System Reach out to every one however difficult the journey is. IDEABATIC is an award-winning social enterprise solving critical last-mile cold chain issues globally. IDEABATIC has developed a last-mile cooling system called SMILE (SMart last-mILE cooling system) that eliminates error and reduces spoilage in temperature-sensitive substances such as vaccines and bio-products. SMILE is freeze-free and fail-safe. It keeps vaccines and bio-products at between 2 and 8 degrees for 3 to 6 days during use without electricity. SMILE has been iterated, tested and field-proven. With the situation of the current pandemic, the logistics for vaccine delivery and … Type: Startup Activities: transporttech Technologies: Synthetic Biology | 1 | 0 | 0 | 2 | |
CardioScale Ltd. CardioScale is an Israeli medical device start-up founded 2012, pursuing a novel patent applied diagnostic for early detection of cardiovascular deterioration in various patients of heart failure and shock. Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 1 | |
CEBIOTEX Providing solutions for patients with cancer by helping surgeons in their oncological interventions. CEBIOTEX leverages nanofiber engineering to create a new medical product which can be infused with multiple agents, with special usefulness for low water solubility drugs. Proprietary technology allows to produce biocompatible-biodegradable membranes (protected by several patents in EU, USA and China), and without chemical interaction between the nanofiber polymer and the agent applied. First medical need targeted is in the field of Oncology: to reduce local recurrence and spreading of tumour cells, by improving local control of cancer after surgery. First product, CEB-01, is composed by our … Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 2 | 2 | 1 | 9 | |
MOWOOT Novel non-invasive, non-drug solution to chronic constipation MOWOOT is a growth stage medical device company targeting INTESTINAL TRANSIT DISORDERS with a novel, purely physical, NON-DRUG & NON-INVASVIVE SOLUTION. MOWOOT (legal name USMIMA SL) emerged out of the prestigious, Stanford Biodesign inspired ,program dHEALTH BCN and was founded in 2014. The Intermittent Colonic Exoperistalsis (ICE) treatment and the MOWOOT device have been developed in collaboration with one of Europes leading neuro-rehabilitation hospitals, Institut Guttmann (Barcelona), is IP protected and clinically proven. The medical device MOWOOT is a novel, purely physical, non-drug and non-invasive solution to treat intestinal transit disorders such as: … Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 7 | 2 | 4 | 7 | |
Aether Biomedical Making bionics accessible Aether Biomedical was founded on the premise of creating healthcare technology and robotics based on human-centered design. A culture focused on building the next generation of bionic devices, utilizing cutting-edge biosignal processing and software integration. After an expansion in Europe and Asia, we are now launching Zeus to the U.S market, with our U.S. headquarters in Chicago, IL. We have developed the Zeus hand, which is the strongest multi-articulating myoelectric hand in the world, providing 30-40% more grip force (152 Newtons) than existing market options! Apart from being the strongest hand, Zeus is highly robust as well. … Type: Startup Activities: deeptech healthtech Technologies: A.I. Robotics Synthetic Biology | 2 | 0 | 1 | 50 | |
MycoWorks We’re on a journey to Grow the Future of Materials. We’re on a journey to Grow the Future of Materials. How? By unlocking the unique properties of mycelium, the root structure of mushrooms. Our patented technology, Fine MyceliumTM, unleashes a new class of materials crafted from nature, engineered for performance, and built for a resilient future. Our impact on future generations steers our innovations today. From our expertise in mycology and materials science to our manufacturing innovations, we’re creating new possibilities for industry. We’re an outstanding team of scientists, engineers, product experts, artists, leaders—and you. Biomaterials, Biotechnology, Design, Composites, Sustainability, … Type: Startup Activities: biotech fashtech Technologies: New Materials Synthetic Biology | 8 | 1 | 1 | 221 | |
SmartBridge Health cancer care as it should be Problem Statistically speaking, one in three people will have cancer in his or her lifetime. Moreover, according to the Journal of Clinical Oncology, up to 44% of cancer diagnoses and treatment plans are incorrect. If there’s any moment in your life when you want to be absolutely certain, it is when you are diagnosed with cancer. It can take weeks or months to reach an oncologist. Imagine the stress, worry and fear of trying to find the right information and the right oncologists when cancer cells are growing exponentially in your body. We have … Type: Startup Activities: healthtech Technologies: Synthetic Biology | 1 | 1 | 0 | 1 | |
Astellas Gene Therapies Astellas Gene Therapies is an Astellas Center of Excellence developing genetic medicines with the potential to deliver transformative value for patients. Based on an innovative scientific approach and industry leading internal manufacturing capability and expertise, we are currently exploring three gene therapy modalities: gene replacement, exon skipping gene therapy, and vectorized RNA knockdown and will also advance additional Astellas gene therapy programs toward clinical investigation. We are based in San Francisco, with manufacturing and laboratory facilities in South San Francisco and Sanford, North Carolina. Content is intended for a US audience. gene therapy and biotechnology Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 3 | 0 | 2 | 409 | |
Labcorp Drug Development In Pursuit of Answers Clear and confident health care decisions begin with questions. At Labcorp, we’re constantly in pursuit of answers. With unparalleled diagnostics and drug development capabilities, we accelerate innovation and provide insight to improve health and improve lives. Whether you’re a patient, provider, researcher or in the pharmaceutical industry, we’re here for you. More than 70,000 employees strong, we serve clients in more than 100 countries. Labcorp (NYSE: LH) reported revenue of $14 billion in FY 2020. Learn more at www.Labcorp.com Drug Development Services , Toxicology Services, Central Labs, Central Laboratory Services , Clinical Trial Management , CRO … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 5 | 1 | 3 | 9,363 | |
Spirecut The future of hand surgery with ultrasound precision. Spirecut is a Swiss MedTech company. We improve treatments for trigger finger and carpal tunnel syndrome, which affect one in seven in their lifetimes. Our patented Sono-Instruments® leverage ultrasound guidance for incision-less, non-invasive procedures, allowing surgeons to achieve higher precision, lower healthcare costs, and enhance patient recovery outcomes. Spirecut's Sono-Instruments® are CE marked, FDA registered, and now available through a network of local distributors in Switzerland, Belgium, the UK, Ireland, Canada, and the United States. Contact us at info@spirecut.com to learn more. Medtech, Medical devices, Hand Surgery, Carpal Tunnel Syndrome, Trigger Finger, … Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 4 | 0 | 2 | 9 | |
Devicare The Digital Therapeutic Company in Urology Devicare is a specialty biotech company dedicated to develop pathbreaking medical treatments in Urology combining the most recent scientific advances in nutritional therapy with digital technologies. Biotechnology, Medical devices , Digital Health , eHealth, Healthcare, and Digital Therapeutics Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 7 | 0 | 4 | 24 | |
FeedVax Oral vaccines for Aquaculture Oral vaccines for farm animals. We developed a platform of oral vaccine that goes in the feed, easy to use, cost effective for the farmer, zero stress for the animal, without contamination or undesirable effects on the consumer. aquaculture, animal production, climate change, and free of antibiotics Type: Startup Activities: cleantech greentech Technologies: Synthetic Biology | 3 | 1 | 3 | 17 | |
Acurable We create accurate and user friendly wearable medical devices intended to be used by patients at home Acurable is a fast-growing, venture backed MedTech start-up with offices in London and Seville. We create accurate and user-friendly wearable medical devices intended to be used by patients at home. Our award-winning, patented technology enables for the first time the automated diagnosis and management of respiratory conditions. It is the product of more than 10 years’ research at Imperial College London by Acurable’s founder, Professor Esther Rodriguez Villegas, and has been recognised as a breakthrough in respiratory medicine, winning some of the most … Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 4 | 0 | 4 | 28 | |
Peptone Bringing order to disorder We are the first in class pre-clinical translational biophysics company focusing on the discovery of novel therapeutics against intrinsically disordered targets. artificial intelligence, structural biology, high performance computing, supercomputers, biotechnology, and intrinsically disordered proteins Type: Startup Activities: biotech deeptech it services Technologies: Synthetic Biology | 46 | 4 | 46 | 42 | |
The EVERY Company Accelerating The World’s Transition To Animal-Free Protein. 🥚🚀 The EVERY Company combines industry-leading expertise in food technology and flavor to enable the foods of tomorrow, today, for the world’s global food and beverage industries. We’re creating game-changing solutions for businesses and brands, with our people and products delivering leveled-up performance, unprecedented outcomes in taste and texture, and animal-free innovation to a host of categories, in line with consumer trends. Along the way, we’re co-creating a better tomorrow, commercializing nutritious, nature-equivalent animal proteins from fermentation that taste and function like the originals, while using significantly less land, water and greenhouse gas … Type: Startup Activities: agritech healthtech Technologies: Synthetic Biology | 16 | 3 | 11 | 180 | |
Desktop Genetics Powering the genome editing revolution with AI-driven design and analysis for cell therapy and drug discovery. Desktop Genetics is an international company established in 2012 to help researchers discover and treat the root genetic causes of human disease. Today, Desktop Genetics is a recognised leader in genome editing technology, staffed by dedicated team of genome editing experts, bioinformaticians and data scientists, driven by the real-world impact of CRISPR technology. We have invested four years developing our core technology, DESKGEN AI, trained on the largest database of genome editing data in the world. DESKGEN AI powers our flagship DESKGEN CRISPR Library … Type: Startup Activities: biotech deeptech Technologies: Generative A.I. A.I. A.I. - Machine Learning Synthetic Biology | 2 | 1 | 0 | 0 | |
Surface Oncology Inc. #lifeunderthesurface #BBJBestPlacesToWork2023,2022,2021 #BostonGlobeTopPlacesToWork2023,2022,2021 Surface Oncology is a clinical-stage immuno-oncology company focused on using its specialized knowledge of the biological pathways critical to the immunosuppressive tumor microenvironment (TME) for the development of next-generation therapies to help patients suffering with cancer. Recent advances in understanding how the immune system fights cancer has created a first wave of immunotherapies with profound benefits for some patients. These first-generation therapies, or "checkpoint inhibitors", have been groundbreaking, but only a relatively small subset of patients is deriving long-term benefit. We believe that the lack of a broad and sustained clinical response is because these first-generation therapies … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 1 | 0 | 17 | |
PVA Med All the Tools You’ll Need to Fabricate Devices In-House. PVA Med offers intuitive 3D printing and digital solutions to orthotists and prosthetists worldwide. We provide the tools, training, and support for O&P practices to incorporate digital workflows into their current patient care. Modernizing your practice creates stress. We create solutions. Please contact us for more information at med@pva.net or +1 518 371-2684. Prosthetics, Prosthetic Covers, 3D Printing, cadcam, orthotics, 3D Printers, and Training Type: Startup Activities: deeptech healthtech Technologies: 3D Printing Synthetic Biology | 0 | 0 | 0 | 5 | |
Agios Pharmaceuticals Where science meets heart. Passionately committed to transforming the lives of people with genetically defined diseases. Agios is a biopharmaceutical company that is fueled by connections. We are passionately committed to applying our leadership in the field of cellular metabolism to create life-changing therapies for people living with rare diseases. The bonds we build with patient communities, healthcare professionals, partners and colleagues help elevate our thinking and propel our science to new heights. These connections, combined with our cellular metabolism expertise, have fueled the development and approval of our first-in-class pyruvate kinase (PK) activator, as well as other investigational therapies. … Type: Startup Activities: biotech healthtech deeptech Technologies: Synthetic Biology | 8 | 2 | 3 | 586 | |
GenEdit Delivering the potential of genetic medicines GenEdit is focused on overcoming the major challenge to genetic medicines: Delivery. We aim to overcome this limitation and enable treatment of a broad range of diseases, having a positive impact on the lives of as many people as possible. The foundation of our company is our NanoGalaxy platform. NanoGalaxy contains a library spanning thousands of unique non-viral, non-lipid, polymer nanoparticles. Using our iterative screening process, we are able to identify polymer nanoparticles that can deliver the needed genetic medicine payload to the needed tissue to treat disease. We are focusing our research on … Type: Startup Activities: biotech deeptech nanotech Technologies: Synthetic Biology | 0 | 0 | 0 | 46 | |
Luminopia Pioneering a new class of treatments for significant neuro-visual disorders. Luminopia is pioneering a new class of treatments for significant neuro-visual disorders. Luminopia is committed to creating digital therapeutics that are both rigorously evaluated for FDA approval and genuinely engaging for patients. As an Innovation Partner of Boston Children’s Hospital, the company is developing its lead product to treat amblyopia, the leading cause of vision loss among children. For more information, visit luminopia.com. Please see Luminopia Directions For Use for more information: luminopia.com/dfu digital health, healthtech, amblyopia, lazy eye, ophthalmology, and neuroscience Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 33 | |
Modern Meadow Where Natural Inspiration Meets Extraordinary Innovation Modern Meadow is a purpose-driven company positioned at the intersection of material science and biology with a mission to be a catalyst for real-world impact on people and the planet. Modern Meadow’s proprietary Bio-AlloyTM and Bio-F@rmTM technology application platforms harness the unique properties of tuned proteins to sustainably move the world away from petrochemical and animal-derived inputs without compromising on performance. These innovations can drop into any existing infrastructures for immediate scalable adoption in the materials, beauty, and other industries. Our close relationship with development partners and production facilities allows companies partnering with Modern … Type: Startup Activities: biotech deeptech Technologies: New Materials Synthetic Biology | 8 | 4 | 3 | 75 | |
Virpax Pharmaceuticals Inc. (Nasdaq:VRPX) Collaborating with NIH & DoD to develop treatment options, targeting unmet needs in three multi-billion dollar markets. Virpax is pioneering advanced healthcare solutions with Probudur, its flagship product leveraging proprietary liposomal encapsulation. Designed for sustained release, Probudur delivers local anesthetic at the wound/incision site, effectively managing post-operative pain for an extended 96 hours. Collaborating through Cooperative Research and Development Agreements (CRADA) and partnering with prestigious institutions like the National Institute of Health/NCATS and U.S. Army Institute of Surgical Research/Department of Defense, we are committed to developing non-addictive treatments. Additionally, our involvement in the Epilepsy Therapy Screening Program (ETSP) underscores our … Type: Startup Activities: biotech deeptech healthtech manufacturing Technologies: Synthetic Biology | 0 | 0 | 0 | 12 | |
Microtech S.R.L. [Automatic translation follows] The logical choice. Microtech was founded in 1964 from an idea of the founder Gaetano Papagno. It is based in Naples and specializes in the promotion, sale and distribution of consumer products, reagents and equipment for molecular, cellular, genetic and biochemical biology in all laboratories of Scientific Research Centers, Universities, C.N.R., Industries, Hospitals and Private individuals. Seriousness, commitment and scrupulousness are the principles that distinguish it, which are recognized by both customers and suppliers. For over 40 years our goal has been to create, in central and southern Italy, a quality organization that contributes, with its products … Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 1 | 1 | 27 | |
Società Italiana di Farmacologia - SIF [Automatic translation follows] At the service of health and citizens: from research to drugs. The Italian Society of Pharmacology (SIF) is a non-profit scientific association, recognized by the Ministry of University and Research. The SIF brings together pharmacologists and pharmacology scholars from the Italian academic community, the world of public and private research and the pharmaceutical industry. Founded in 1939, today the Society is led by a President in office, a President-Elect, a Past President and a Board of Directors consisting of seven members, from which a Secretary is elected. Mission: • promote research in the field of basic, applied … Type: SMB Activities: deeptech Technologies: Synthetic Biology | 2 | 0 | 1 | 20 | |
Value Relations Lavoriamo al vostro fianco per sviluppare relazioni di valore. Value Relations is a strategic consultancy firm with an exclusive focus on the Healthcare sector. When relations matter - to support any player of the Healthcare and Lifesciences (pharma, medical device, scientific societies, Patients groups, public and private hospitals) - Value Relations is present with its services of Public & Government Affairs, Market Access, Patient Advocacy, Communication, and Digital PR. - Value Relations è una società di consulenza strategica con una specializzazione esclusiva nel settore dell’Healthcare. Quando le relazioni contano – per supportare qualsiasi attore dell’Healthcare e Lifesciences (farmaceutica, dispositivi medici, … Type: SMB Activities: consulting govtech Technologies: Synthetic Biology | 1 | 0 | 1 | 21 | |
Egualia – Industrie Farmaci Accessibili A better future. For everyone. Egualia (formerly Assogenerici) is the Italian Federation of Industries for Accessible Medicines which today represents more than fifty companies, over 95% of the companies producing generic, biosimilar and value-added medicines. Founded in 1993, it is a member of the European association of the sector, Medicines for Europe, and welcomes multinational and Italian companies present throughout the territory, which produce both for the domestic and foreign markets, as well as companies engaged in the production of drugs on behalf of third parties for the entire pharmaceutical industry. Generics and biosimilars cover 80% of therapeutic areas and … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 7 | 0 | 7 | 21 | |
OPPI India Partnering India since pre-independence to improve patient safety & provide healthcare access to all. #BharatKeLiye The Organisation of Pharmaceutical Producers of India (OPPI) was established in 1965 and represents the research-based pharmaceutical companies in India. OPPI remains committed to supporting the nation’s healthcare objectives and collaborating with all stakeholders to find sustainable solutions. OPPI believes the need for innovation must be balanced with the necessity for more accessible medicines, within a robust IP environment. Vision: OPPI is an organisation of research and innovation driven pharmaceutical companies committed to addressing India's healthcare needs by: - Facilitating greater access to quality healthcare … Type: SMB Activities: healthtech biotech deeptech Technologies: Synthetic Biology | 17 | 2 | 17 | 16 | |
Medindia Health Network Medindia.com (or .net) is Asia’s premier health portal providing a range of services to both healthcare consumers and the medical professionals. Medindia has a net presence of seven years and was started as a social mission to provide the consumers with essential health related information in simple language. Over the years it has evolved into Asian regions most comprehensive portal in the health sector in terms of content, viewer ship, technology leadership and domain expertise. The portal is headed by eminent doctors with a team of editors, programmers and designers. The site recommends registration to fully utilize its services that … Type: SMB Activities: healthtech Technologies: Synthetic Biology | 2 | 1 | 2 | 74 | |
Aerogen We're devoted to improving the lives of vulnerable patients worldwide through superior aerosol drug delivery. *Medtech Company of the Year 2020/2021* Aerogen improves the lives of vulnerable patients worldwide through superior aerosol drug delivery – ultimately transforming respiratory care. Dedicated to scientific excellence, Aerogen innovates based on what’s best for the patient and care team and is focused on: - Bringing peace of mind to patients and loved ones by safely and rapidly delivering more medication to the lungs, increasing speed of recovery. - Helping care providers more effectively treat patients, while also empowering them to focus on strategic tasks … Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology | 11 | 1 | 3 | 545 | |
European Society of Retina Specialists (EURETINA) EURETINA is the largest society of retina specialists in Europe The European Society of Retina Specialists (EURETINA) was established in 1999 to promote the sharing of knowledge among European vitreoretinal and macula specialists. Our annual congresses are the highlight of the Society's annual activity, and since the 1st EURETINA Congress in 2001, participation has expanded rapidly from 211 to over 5,000 in recent years. The congress aims to promote the exchange of knowledge and encourage critical discussion of new research and techniques between vitreoretinal and macula specialists worldwide. EURETINA actively promotes new diagnostic developments, advances in vitreoretinal surgery, the development … Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech Technologies: Synthetic Biology | 5 | 2 | 4 | 25 | |
Royal Trinity Hospice The local hospice for south west & central London. Together with you to the end of life, making the best of every moment Royal Trinity Hospice is the UK's oldest hospice, and provides expert palliative and end of life care for 2,400 people every year. We are the only specialist palliative care provider for 750,000 people across seven boroughs in central and south-west London. As well as nursing and medical care, we provide support to patients and their friends & families through welfare advice, counselling and bereavement support, physiotherapy and occupational therapy, art therapy and therapeutic massage. We are a … Type: SMB Activities: healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 235 | |
NovaBiotics Ltd Developing first-in-class solutions for unmet health and personal care needs Results through innovation. We are an innovative biotechnology group with two divisions. Our consumer health arm has commercial products for the personal care market addressing nail, skin, scalp and hair issues. NovaBiotics pharma division has advanced clinical-stage product candidates for medically unmet, life-limiting inflammatory, infectious and respiratory disease. Our highly disruptive solutions to personal care and health needs address significant global markets. biotechnology, biologics, infectious disease, and drug discovery & development Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 10 | 3 | 6 | 14 | |
Forma Therapeutics Dedicated to transforming the lives of patients with rare hematologic diseases and cancers. Forma Therapeutics (Nasdaq: FMTX) is a clinical-stage biopharmaceutical company focused on the research, development and commercialization of novel therapeutics to transform the lives of patients with rare hematologic diseases and cancers. Our R&D engine combines deep biology insight, chemistry expertise and clinical development capabilities to create drug candidates with differentiated mechanisms of action focused on indications with high unmet need. Our work has generated a broad proprietary portfolio of programs with the potential to provide profound patient benefit. We aim to create futures for patients, their families … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 0 | 1 | 156 | |
Pyxis Oncology Charting a course to therapeutics for difficult-to-treat cancer. Pyxis Oncology is transforming the lives of patients with cancer by advancing our differentiated portfolio of biologics that specifically target tumor cells and overcome immune suppression. We believe that antibody-drug conjugates (ADCs) and immunotherapies have the potential to address difficult-to-treat cancers and improve patient outcomes. Immuno-oncology and oncology Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 3 | 1 | 2 | 64 | |
BLACKROLL AG Do it your health. We offer people of all ages and sports levels the possibility to improve their flexibility, balance, and strength by doing simple exercises and applying self-massage. We create the ideal tools to complement traditional treatment methods and make fascia- and functional training available to all. Train, release and restore - all in one. - - - In 2007, BLACKROLL® was developed in Germany by Jürgen Dürr. As of 2012, BLACKROLL® firmly established itself on the market, and got well supported and recommended by leaders in the health - sports and therapeutic industry. In the autumn of 2013 … Type: Startup Activities: healthtech Technologies: Synthetic Biology | 1 | 1 | 1 | 107 | |
CureMatch, Inc. AI-based Precision Medicine Decision Support for Oncology CureMatch is a leader in AI-based precision medicine, digital decision support solutions that support cancer treatment. Created to empower oncologists with world-class research and sophisticated AI algorithms, the CureMatch Decision Support System assists the doctor with understanding therapeutic options that are personalized to the unique molecular profile of the individual patient’s tumor. digital health, oncology, decision support software, AI, precision medicine, and combination therapy Type: Startup Activities: healthtech deeptech biotech Technologies: A.I. Synthetic Biology | 5 | 1 | 4 | 26 | |
Sisu Global Designing & commercializing medical devices for all healthcare ecosystems. Sisu Global develops patented, cutting-edge, world-class medical devices that are designed to save lives, enable patient access to care and increase resources for healthcare ecosystems. Our medical device, Hemafuse, is a highly effective, mechanical alternative to donor blood and available in Ghana, Kenya, India, and Tanzania. Hemafuse increases access to blood by enabling clinicians to capture a patient’s blood, filter it, and return fresh, whole blood back to that same patient. Hemafuse provides immediate access to blood transfusion across trauma, obstetric, general, and orthopedic surgeries with internal bleeding. We have raised … Type: Startup Activities: deeptech healthtech civictech Technologies: Synthetic Biology | 8 | 2 | 8 | 10 | |
Ikena Oncology Patient-directed oncology therapies across pathways relevant in tumor and immune cells Ikena is a targeted oncology company focused on developing novel cancer therapies targeting key signaling pathways that drive the formation and spread of cancer. Our programs focus on key cancer driver pathways that are well-validated in scientific literature but lack approved or effective therapies and therefore have the potential to address high unmet medical needs. By leveraging our deep understanding of discovery chemistry, translational science, and patient-centric drug development, we have built a deep pipeline of wholly owned and partnered programs focused on genetically defined or biomarker-driven cancers, which … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 5 | 0 | 5 | 30 | |
UNYQ LIKE NO OTHER UNYQ with headquarters in San Francisco with global reach creating products for prosthetics or what we call UNYQ Wears. We create industry-leading, data and biometrical designed wears, reimagining medical devices using 3D printing to create products that heal you or reflect you. UNYQ uses emerging technologies and creates next-generation of wears that are simultaneously aesthetically beautiful yet practical and functional, our wears living close to our customers every day. Our first line of wears was a range of prosthetic covers for upper and lower limb amputees. These covers offer amputees personalization (colors and style), symmetry and protection. … Type: Startup Activities: deeptech healthtech fashtech Technologies: 3D Printing A.I. Synthetic Biology | 4 | 2 | 0 | 31 | |
Hound Labs, Inc. SAFETY + FAIRNESSTM Hound Labs, Inc. develops advanced breath testing technologies to address leading public health and safety issues. The Company’s flagship product, the HOUND® CANNABIS BREATHALYZER, introduces the drug testing industry’s shortest cannabis detection window, giving employers a practical and objective solution to detect and deter recent use. The ultra-sensitive, analytical test identifies active THC molecules in breath, limiting cannabis detection to the workday. As cannabis legalization increases employee access to THC, employers are seeking a solution to continue testing for the drug while balancing workplace safety with employee fairness and privacy. Hound Labs’ groundbreaking innovation returns an objective … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 46 | |
Pharmap [Automatic translation follows] Your Pharmacy products, delivered to your home in 60 minutes Pharmap is the leading pharmaceutical home delivery solution in Italy that allows you to receive any Pharmacy product (including prescription drugs) in 1 hour, or in the preferred time slot. The service, born in 2016, now has over 400,000 users in more than 1,000 municipalities in Italy (including Milan, Rome, Genoa, Bologna, Florence, Turin, Palermo, Cagliari). More than 2,500 pharmacies manage home deliveries for their customers through Pharmap. In 2019, Pharmap entered the ranks of the 50 most innovative scale-ups in Italy. Delivery, Pharmacy, and Pharmaceutical products Tags: H2020 Type: Startup Activities: consumer services Technologies: Synthetic Biology | 2 | 0 | 1 | 46 | |
Neuromod Devices A pioneer in the development of bimodal neuromodulation treatments Neuromod is a medical device company formed to advance the science of bi-modal neuromodulation. We are committed to delivering treatments that significantly reduce the suffering of underserved patient populations who live with chronic and debilitating conditions globally. Our goal is to design products that empower patients to take control of their own treatment, delivering targeted therapies that integrate seamlessly into a modern lifestyle. Neuromod has developed and patented a bi-modal neuromodulation technology that it is evaluating for neurological disorders including chronic tinnitus, a condition affecting 10% of the adult population and … Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 4 | 0 | 3 | 64 | |
MiNA Therapeutics Activating RNA, mastering disease Harnessing an innate mechanism of gene activation, MiNA Therapeutics' platform enables the development of new medicines that restore normal function to patients’ cells. We are applying our technology and clinical know-how to transform the therapy landscape of severe liver and other diseases. Gene activation, RNA therapeutics, Liver disease, and Drug discovery Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 4 | 1 | 4 | 33 | |
QuantuMDx Transforming Point of Need Multiplex Diagnostics QuantuMDx is a progressive MedTech company passionate about creating multiplex molecular diagnostic solutions for use at the point of need. MedTech, Molecular Diagnostics, Multiplex Molecular Diagnostics, Point of Care, Point of Need, COVID-19, Medical device, Diagnostic device, DNA extraction, TB, Sepsis, Transcriptomics, PCR, Microarray, Assay Development, Assay Feasibility, Rapid Diagnostics, Respiratory Infections, Sexually Transmitted Infections, Host Response, and In vitro Diagnostics Type: Startup Activities: deeptech nanotech biotech healthtech Technologies: Synthetic Biology | 8 | 0 | 7 | 96 | |
MyCognition Changing the world one mind at a time MyCognition has developed NHS approved apps that assess and promote brain health through cognitive fitness. The apps are CE Marked (class 1A medical device) and recently we obtained a prestigious UCL award for our research. Our apps work on all devices, in all settings, are self-administrated and provide insightful reports and automatically assess to personalise cognitive training. They work in people of all ages, gender and health states. MyCognition enhances brain health and performance through the use of our cognitive fitness assessment and training programmes, which are self-administered, easy to access and … Type: Startup Activities: healthtech Technologies: Synthetic Biology | 7 | 1 | 1 | 1 | |
Cellomatics Biosciences Ltd Our expertise, Your discovery Cellomatics Biosciences Ltd. (www.cellomaticsbio.com) is a laboratory-based Contract Research Organisation (CRO) specialised in Oncology/Immuno-Oncology, Immunology/Inflammation and Respiratory therapeutic areas. Based at Colwick Quays Business Park, Nottingham UK, our experienced scientific team offers bespoke and innovative preclinical in vitro bioassay services to support our client’s drug development programmes. We work with diverse group of global clients including early start-ups, virtual/small to medium sized Biotechnology and Pharmaceutical companies. Multiplex Immunoassay, Target and biomarker validation, In vitro functional assays, Molecular Biology, Receptor binding, Toxicity testing, Immuno-Oncology, Oncology, Immunology, Inflammation, and Respiratory Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 0 | 0 | 18 | |
Exscientia Better drugs, faster Exscientia is a global pharmatech company using patient-first artificial intelligence (AI) to discover better drugs, faster. Our mission is to encode, automate and transform every stage of the drug design and development process, by combining the latest AI techniques with experimental innovation, to enable the design of patient centric drug candidates with an improved probability of success. Our validated platform has delivered the first three AI-designed drugs to enter clinical trials and is the first AI system proven to improve clinical outcomes in oncology. We’ve significantly accelerated pre-clinical drug discovery, with 10x productivity improvement in delivering a … Type: Startup Activities: biotech deeptech manufacturing Technologies: A.I. Synthetic Biology | 8 | 3 | 5 | 434 | |
Biogelx We design and supply artificial tissue environments for cell culture & bioprinting applications. Biogelx is helping people work in translational science, drug discovery and tissue engineering by 'making in vitro cell cultures more in vivo'. We do this through manufacturing and supplying 3D cell cultures that can be tuned to specific tissues and synthetic bio-inks that are reproducible, scalable, easy to handle and suitable for clinical decision making. Our portfolio of biomaterials is comprised of synthetic peptide hydrogels that act as extracellular-matrix environments to support cell growth. In addition, the chemical and physical properties of our biomaterials can be precisely … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 0 | 0 | 2 | |
Open Bionics Turning disabilities into superpowers Open Bionics: Open Bionics is a prosthetics company developing affordable, assistive devices that enhance the human body. We've started by introducing the Hero Arm, a stylish multi-grip bionic arm. Current upper limb prostheses exist as hooks, grippers, or expensive bionic hands. We're on a mission to make beautiful bionic limbs more accessible. Aged 17, Joel Gibbard began tinkering with robotic hands. There was something about the movement of a disembodied humanoid hand that captured his imagination. Hundreds of prototypes and many crates of failures later, in 2014, Joel co-founded Open Bionics with Samantha Payne. With the … Type: Startup Activities: deeptech healthtech manufacturing Technologies: Robotics Synthetic Biology | 12 | 5 | 2 | 54 | |
Mogrify Transforming the lives of patients with degenerative diseases through a novel class of in vivo reprogramming therapies. Mogrify® has developed a proprietary suite of platform technologies that utilize a systematic big-data approach to direct cellular reprogramming (Rackham et al., Nature Genetics, 2016) and the maintenance of cell identity (Kamaraj et al., Cell Systems, 2020). The platforms, MOGRIFY® and epiMOGRIFY®, developed over a 12-year period via a multi-national research collaboration, deploy next-generation sequencing, gene regulatory and epigenetic network data to enable the prediction of the transcription factors and growth factors required to produce any target human cell type from any source … Type: Startup Activities: deeptech biotech Technologies: A.I. A.I. - Machine Learning Synthetic Biology | 9 | 0 | 7 | 40 | |
Genix Pharma (Private) Limited Genix Pharma (Pvt.) Ltd is a leading Pharmaceutical manufacturer & marketing company, based in Pakistan with its business expanding throughout Asian & African Markets, after its establishment in 2004, Genix Pharma has been recognized as the fastest growing Pharmaceutical Company in its earliest years, it has been ranked among the top 40 companies including MNC’s, We have a work force of more than 1400 professionally trained and highly qualified employees, state of the art manufacturing facility, Well-furnished Quality Control department with top of the line and highly sophisticated Equipment, motivated by a passion to succeed, our company is committed to … Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology | 1 | 1 | 1 | 1,077 | |
AIG Hospitals India's most advanced Multi Speciality Hospital with Superlative Care AIG Hospitals, Hyderabad AIG Hospitals is a unit of Asian Institute of Gastroenterology, India’s foremost Gastroenterology hospital. It is a state-of-the-art super specialty Hospital and is a world-leader to undertake Transplant surgeries including Liver, Kidney, Heart, Pancreas and Islet Cell. We believe in creating a positive and nurturing environment that is conducive to healing. Cardiology , Gastroenterology, Hepatology, Oncology, Neurology & Neurosurgery , Pulmonology, Andrology, Orthopedics, Multi-Organ Transplants, Nephrology, and Urology Type: SMB Activities: healthtech Technologies: Synthetic Biology | 1 | 0 | 1 | 1,663 | |
Trivitron Healthcare Speaking Your Language of Care! Since 1997, the journey of Trivitron Healthcare as a medical technology company providing affordable healthcare solutions has woven a fascinating thread of inspiration to many healthcare providers. Having solid expertise in research and development, Trivitron manufactures and distributes exceptional medical technology products to 180+ countries. With 15 certified manufacturing facilities in India, USA, Finland, Turkey & China; Trivitron spearheads innovation in the fields of In-Vitro Diagnostics, Imaging & Radiology, Radiation Protection, Newborn Screening, Critical Care & ICU Solutions and Renal Care Portfolio, thus, engraving its name as a holistic healthcare provider. 15 Manufacturing Facilities | … Type: SMB Activities: healthtech manufacturing Technologies: Synthetic Biology | 3 | 0 | 1 | 579 | |
Antiverse Designing functional antibodies for the most challenging targets. Antiverse is a Welsh techbio company specialising in antibody design for challenging drug targets, such as GPCRs and ion channels. We exist to create new enabling technologies that bring new therapies to patients to change lives. Headquartered in Cardiff, UK and with offices in Boston, MA, we combine state-of-the-art machine learning techniques and advanced cell line engineering to develop de novo antibody therapeutics. Machine Learning, Antibodies, and Drug discovery Type: SMB Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning Generative A.I. Synthetic Biology | 7 | 1 | 8 | 16 | |
Penlon Ltd World renowned medical devices Penlon manufactures and distributes products and systems for anaesthesia, intubation, oxygen therapy and suction, and medical gas pipeline. We also design and install medical gas pipeline networks. Quality Systems and products are certified to CE and ISO standards, and approved by the CSA, FDA, and other agencies. Penlon supplies reliable products of the highest quality. Penlon constantly reviews its product design, manufacturing processes and systems, and training procedures to ensure its customers deliver optimum patient care. Manufacture, Distributor, Systems for anaesthesia, intubation, and oxygen therapy and suction Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology | 7 | 3 | 7 | 108 | |
Fusion Antibodies Antibody Services from Discovery to Clinical Supply Since 2001, Fusion Antibodies has been dedicated to the discovery and early development of antibodies to help bring about a positive change in the healthcare industry. We offer a complete range of antibody-related services in Discovery, Engineering and Supply and have guided hundreds of projects through critical preclinical stages. Fifteen of our client’s projects have advanced to clinical stages, some as far as Phase II. We deliver a superior service for the development of antibodies by beginning each project with the end in mind. Our scientists are experts in early stage discovery of … Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 5 | 1 | 1 | 29 | |
PIR International Executive & Interim Search for Life Sciences PIR International provides innovative senior level recruitment solutions to small and multinational life science organisations. We are recruitment specialists who understand the vision, commercial imperatives and research needs of the world’s leading life science organisations. Based in London, UK, PIR serves clients across the international life science sector, spanning pharma, biotech, diagnostic and medical device companies. Using over 100 years of combined experience and a powerful industry network, we find the right senior talent to drive organisations forward. PIR International specialise in C-suite and senior management roles, whether on a permanent or interim … Type: SMB Activities: deeptech hrtech biotech healthtech transporttech Technologies: Synthetic Biology | 0 | 0 | 0 | 13 | |
Myricx Bio Developing a new class of ADCs based on NMT inhibition to treat cancer We are a UK biotech company focused on the discovery and development of a completely novel class of selective cytotoxic payloads for antibody drug conjugates (ADCs), based on inhibitors of N-myristoyltransferases (NMT) for the treatment of cancer. Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 1 | 2 | 13 | |
GrainSense GrainSense has developed NIR solutions for instant grain quality testing. Learn more: www.grainsense.com A Nordic innovation transformed traditional, bulky Near-Infrared (NIR) spectroscopy equipment into a convenient format to help agribusinesses with instant grain quality tracking. Handheld GrainSense Analyzer uses (NIR) spectroscopy technology found in laboratory instruments – in a battery-powered, handheld device. You get reliable protein, moisture, oil and carbohydrate contents in seconds from just a few kernels. The GrainSense Flow Analyzer has been developed for analyzing real-time grain quality in an environment where grains are actively flowing. Whether installed in an elevator of a combine harvester or in a … Type: Startup Activities: agritech Technologies: Synthetic Biology | 0 | 0 | 0 | 16 | |
Sooma Medical Depression treatment at home. Transforming psychiatric and neurological care with accessible therapies. Sooma Oy is developing, manufacturing and marketing a non-invasive therapy devices for neurological and psychiatric disorders (depression and chronic pain). Sooma uses transcranial direct current stimulation (tDCS) technology. Our technology is trusted by over 150 clinics worldwide. We feel that everyone deserves high quality care. With our Sooma therapies, we want to provide an effective and safe way to treat disorders within psychiatry and neurology. We want to offer a safe, drug-free treatment option with minimal side effects, that minimises any discomfort that might otherwise come with treating … Type: Startup Activities: healthtech deeptech biotech manufacturing Technologies: Synthetic Biology | 7 | 0 | 6 | 24 | |
OMEICOS Therapeutics GmbH Developing 1st-in-class therapeutics based on the profound understanding of omega-3 fatty acid metabolism OMEICOS Therapeutics has discovered a series of metabolically robust synthetic analogues of omega-3 fatty acid-derived epoxyeicosanoids that have the potential to treat mitochondrial dysfunction, inflammatory, cardiovascular and other diseases. Epoxyeicosanoids activate cell type-specific endogenous pathways that promote organ and tissue protection. OMEICOS’ small molecules are orally available and show improved biological activity and pharmacokinetic properties compared to their natural counterparts. The currently active PMD-OPTION Phase 2a clinical study is evaluating OMEICOS’ lead development program OMT-28 in patients with Primary Mitochondrial Disease. Drug development, Cardiovascular Research, and Mitochondrial … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 1 | 2 | 9 | |
RetroBrain R&D GmbH Spielend körperlich und geistig aktiv sein Retrobrain is researching and developing novel serious gaming approaches to solve challenges in medical care and therapy with a particular focus on the elderly, Alzheimer's disease as well as motion/gesture based control schemes utilizing Kinect and other motion-sensing equipment. More generally, we are working with researchers and teams around the world to explore how serious therapeutic games can best be used to improve mental and physical health and to alleviate or prevent illness. We are currently implementing our award-wining proof-of-concept with technology partners including Microsoft Germany, research partners at the Humboldt University of Berlin, … Type: Startup Activities: healthtech silvertech games Technologies: Synthetic Biology | 3 | 1 | 2 | 15 | |
Instituto de Biología Molecular y Celular de Plantas, IBMCP (UPV - CSIC) [Automatic translation follows] Discovering from green - Scientific research aimed at obtaining plants with better productivity, fruit quality or with high added value properties (of interest to the consumer, farmers and the agri-food industry) and more resistant to stress, as well as less dependent on chemical treatments, thus contributing to a less aggressive agriculture with the environment. - Advanced services in Genomics, Proteomics, Metabolomics, Bioinformatics, Microscopy, Quantification of Plant Hormones, DNA Sequencing and Gene Expression Analysis. - Training of research staff. Biotechnology, Molecular Biology, Genomics, Proteomics, Bioinformatics, Metabolomics, Systems Biology, and Synthetic Biology Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 3 | 0 | 0 | 185 | |
AMSBIO AMSBIO is a global supplier of research products and custom services for biological and pharmaceutical research Accelerate your discovery with exceptional service and innovative, cutting-edge life science products Founded over 35 years ago, AMSBIO is a premier life sciences supplier dedicated to meeting diverse research needs. AMSBIO’s product lines are carefully curated with top tier products to give high choice and quality control, as well as offering advanced, flexible and tailored custom services. In addition, AMSBIO’s focus on generally underserved areas, such as Glycobiology, highlights a wider mission to advancing niche fields in life science. AMSBIO is ISO9000 Certified to … Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 2 | 0 | 2 | 33 | |
DiaMonTech AG Say goodbye to finger pricking! Awarded for “most innovative German startup” from German business magazine Bilanz, DiaMonTech has developed a medical device that non-invasively measures your blood glucose without finger pricking, a drop of blood, or a test strip. Simply relax your fingertip on the sensor, wait 5 to 15 seconds, and your blood glucose level will be displayed. Our patented technology works with an invisible infrared light beam that looks into your skin and counts glucose molecules. Diabetes is a global challenge. More than 400 million people worldwide suffer from the disease. Our goal is to make checking your … Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 29 | |
Naturae [Automatic translation follows] Europe's first biofactory dedicated to obtaining natural and healthy products based on biotechnology. Naturae © is a set of ingredients that can be added to all types of food and drink and that, among other beneficial effects for our health, safely and naturally activate the immune system, enhance cholesterol control and improve cardiovascular circulation. Naturae © is obtained from proprietary and registered strains of natural mushrooms, such as shiitake or yeast. It is completely free of genetically modified organisms (GMO) and its extraction is carried out naturally, using patented methods, without the addition of synthetic substances. Naturae … Type: Startup Activities: foodtech Technologies: Bio sourced materials Synthetic Biology | 1 | 0 | 0 | 34 | |
Dewpoint Therapeutics Translating condensate biology into medicine. Dewpoint is the first company to apply the emerging understanding of biomolecular condensates to drug discovery. Dewpoint develops drugs for the vast range of conditions that are regulated by condensates or arise from the dysfunction of condensates. Dewpoint currently has multiple programs across an ambitious pipeline spanning oncology, neurodegeneration, cardiopulmonary, and virology indications, and collaborations with leading global academic and pharmaceutical partners, including Bayer, Merck, and Pfizer. Dewpoint scientists work in Boston, Dresden and Frankfurt to translate condensate biology into breakthrough treatments for diseases previously considered untreatable. biomolecular condensates, oncology, neurodegeneration, cardiopulmonary, virology, insulin resistance, … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 0 | 2 | 128 | |
Optimum Nutrition Leader in the sports nutrition industry empowering people everywhere to realize their potential and achieve their goals. Optimum Nutrition, Inc. (ON) is part of the Glanbia global nutrition group and has been setting the Gold Standard in sports nutrition for more than 30 years - helping performance focused athletes achieve their goals We are the creators of 100% Whey Protein (The Worlds #1 Protein Powder), Gold Whey Standard 100% Casein, Essential Amino Energy, Diet Products, Strength and Recovery Supplements, and other health and nutrition products. Type: Startup Activities: healthtech Technologies: Synthetic Biology | 1 | 1 | 0 | 94 | |
Havas Life Rare The Premier Commercialization and Marketing Partner for Orphan Drugs and Rare Disease Markets Worldwide Havas Life Rare is the premier commercialization and marketing partner for orphan drugs and rare disease markets. In a setting where natural history, diagnosis, care pathways, awareness, and access are almost always underdeveloped, it takes rigorous strategic thinking, deep medical knowledge, and extensive rare disease commercial experience to navigate the right path forward. Type: Startup Activities: healthtech martech Technologies: Synthetic Biology | 3 | 1 | 0 | 36 | |
Xkelet We develop Medical Device Software for professionals to produce personalized products using AI to automatize the process We want to change the current immobilization methods such as plaster and current orthotic systems, to solve the problems that come from these immobilization systems. The immobilizations are printed with 3D printing technology and suitable for accurate measurements of the patient's anatomy. With Xkelet, the patient can shower and dry without problems, no longer scratching due to scaling of the skin, in case the injury includes a wound already well derived by the fracture itself as an operative process, the patient and the … Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 4 | 0 | 3 | 16 | |
Apprentice.io Cloud-driven manufacturing excellence Apprentice provides an all-in-one, cloud-native platform (Tempo Manufacturing Cloud) that is purpose-built for regulated industries, and covers a wide range of manufacturing use cases across multiple industry verticals. Within life sciences, Tempo accelerates the end-to-end drug product lifecycle by connecting together distributed teams and sites, helping them execute better on the shop floor, and optimizing their operations through enterprise-wide visibility. Apprentice is trusted by global manufacturing leaders across various regulated industries. Tempo users belong to organizations responsible for contract manufacturing, cell & gene therapy, CRISPR technology, biopharma, biotechnology and adjacent industries. digitization, manufacturing execution, and connected manufacturing Type: Startup Activities: deeptech biotech Technologies: A.I. A.I. - Machine Learning Synthetic Biology | 10 | 0 | 2 | 116 | |
Causeway Sensors Limited Causeway Sensors uses nanotechnology to provide better candidate selection during drug development. The company spun-out after years of high-impact research at Queen's University Belfast. Our unique nanochip platform brings real-time, label-free kinetic analysis to areas of biotherapeutic production where such data cannot currently be collected. More data at critical points of production helps pharma companies ensure that only the best drug candidates progress to clinical trials. The platform can be incorporated into a multitude of form factors, ranging from a high-throughput screening instrument to an in-line cell culture monitoring tool. Biosensing, Protein - Protein Interactions, Binding Kinetics, Biotechnology, Biotherapeutics, Antibody … Type: Startup Activities: biotech deeptech Technologies: Data Analytics Synthetic Biology | 3 | 0 | 2 | 14 | |
Phico Therapeutics Ltd. Phico Therapeutics is a biotechnology company advancing the war on antibiotic resistance with engineered phage therapy. At Phico, we are developing a unique antibiotic technology to address one the most urgent challenges facing medicine today – how to destroy multi-drug resistant bacteria, the so-called “superbugs”. Our patented platform utilises an antibacterial protein, SASP to inactivate bacterial DNA and cause rapid destruction of target bacteria. With a number of advantages over conventional antibiotic classes, SASPjectTM could form the basis for a new generation of antibiotics to overcome antimicrobial resistance. Watch our animation to discover how our technology works: https://www.youtube.com/channel/UCjPndK0F9ufmEy9fBQFTsUg Twitter: @Phicotx … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 0 | 3 | 12 |